Edition:
United States

IP Group PLC (IPO.L)

IPO.L on London Stock Exchange

112.60GBp
20 Feb 2018
Change (% chg)

3.20 (+2.93%)
Prev Close
109.40
Open
108.00
Day's High
115.20
Day's Low
108.00
Volume
419,193
Avg. Vol
1,105,653
52-wk High
176.74
52-wk Low
107.20

Chart for

About

IP Group plc (IP Group) is a United Kingdom-based intellectual property commercialization company. The Company develops intellectual property-based businesses. The Company operates through three business segments: University partnership business, Venture capital fund management and In-licensing activity. The Company's University... (more)

Overall

Beta: 0.88
Market Cap(Mil.): £1,156.78
Shares Outstanding(Mil.): 1,057.38
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 39.64 17.28
EPS (TTM): -- -- --
ROI: -- 5.78 35.61
ROE: -- 9.66 17.17

BRIEF-IP Group Says Autifony Therapeutics Signs 627.5 Mln Euros Collaboration Deal With Boehringer Ingelheim​

* ‍PORTFOLIO COMPANY AUTIFONY THERAPEUTICS SIGNS EUR 627.5 MILLION COLLABORATION AGREEMENT WITH BOEHRINGER INGELHEIM​ Source text for Eikon: Further company coverage:

Dec 18 2017

BRIEF-IP Group ‍welcomes Touchstone Innovations' recommendation to shareholders to accept offer​

* ‍WELCOMES ANNOUNCEMENT MADE BY TOUCHSTONE INNOVATIONS PLC RECOMMENDING THAT TOUCHSTONE SHAREHOLDERS ACCEPT OFFER​

Oct 18 2017

BRIEF-IP Group says Touchstone Innovations offer now unconditional

* IP GROUP PLC - ‍ACCEPTANCES IN EXCESS OF 96%; ACCEPTANCE CONDITION SATISFIED IN TOUCHSTONE INNOVATIONS DEAL​

Oct 18 2017

BRIEF-UK's CMA not to refer IP Group, Touchstone Innovations deal to phase II probe

* UK'S CMA - ‍ DECIDED NOT TO REFER IP GROUP, TOUCHSTONE INNOVATIONS DEAL TO PHASE 2 INVESTIGATION Further company coverage: (Bengaluru Newsroom)

Oct 17 2017

BRIEF-IP Group's Istesso announces positive outcome from P1 study

* ISTESSO ANNOUNCES POSITIVE OUTCOME FROM P1 STUDY Source text for Eikon: Further company coverage:

Aug 30 2017

BRIEF-UK'S CMA says considering IP Group-Touchstone Innovations deal

* UK'S CMA SAYS CONSIDERING WHETHER OR NOT THAT ANTICIPATED ACQUISITION BY IP GROUP OF TOUCHSTONE INNOVATIONS WILL RESULT IN CREATION OF RELEVANT MERGER SITUATION (Bengaluru Newsroom: +91 80 6749 1136)

Aug 29 2017

BRIEF-IP Group updates on offer for Touchstone, capital raising

* PROPOSED TRANSACTION IN FINAL STAGES OF PRE-NOTIFICATION PROCESS WITH CMA FOLLOWING WHICH FORMAL 40 BUSINESS DAY PHASE 1 REVIEW PERIOD BY CMA SHALL COMMENCE; ANTICIPATED TO OCCUR SHORTLY

Aug 25 2017

BRIEF-IP Group says Istesso has started Phase 2a trial for rheumatoid arthritis drug

* Istesso commences phase 2a for mbs2320 in rheumatoid arthritis and expands research and development collaboration with Janssen

Aug 22 2017

Earnings vs. Estimates